Resource Summary

Clinical Question:
Can patients with osteoporosis who have taken bisphosphonates for five years discontinue treatment without increasing future fracture risk?

Bottom-line:
Available evidence suggests that after five years of treatment^ discontinuation of bisphosphonates carries little to no increased future fracture risk. Choosing appropriate patients to continue therapy beyond five years^ and determining when or if to reinitiate therapy in those discontinued^ remains uncertain.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2013-12-2
Last Updated on PCR: 2017-03-31 15:14:41